Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding

Kidney International

Volumn 55, Issue 3, 1999, Pages 907-916

  Youssef, Sherif ^b   Nguyen, Dominique T ^b   Soulis, Tina ^b   Panagiotopoulos, Sianna ^b   Jerums, George ^b   Cooper, Mark E ^a  

^a Repatriation Medical Center   (Australia)

^b NONE

Author keywords

AGEs; Autoradiography; Diabetic nephropathy; Glucose control; Hemoglobin; Proximal tubule

Indexed keywords

AMINOGUANIDINE; GLUCOSE; HEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLYCATION; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING;

EID: 0009770755     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.055003907.x     Document Type: Article

References (44)

1. Brownlee M: Lilly Lecture 1993: Glycation and diabetic complications. Diabetes 43:836-841, 1994
2. Soulis Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
3. Chen CH-J, Cerami A: Mechanism of inhibition of advanced glycosylation by aminoguanidine in vitro. J Carbohydr Chem 12:731-742, 1993
4. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R: Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651-653, 1992
5. Vlassara H, Fun H, Makita Z, Krungkrai S, Cerami A, Bucala R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Nait Acad Sci USA 89:12043-12047, 1992
6. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen JX, Van SD, Brett J, Cao R, Kuwabara K, Costache G, Simionescu N, Simionescu M, Stern D: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 91:8807-8811, 1994
7. Vlassara H, Fun H, Donnelly T, Cybulsky M: Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447-456, 1995
8. Neeper M, Schmidt AM, Bretti J, Van SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
9. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Feng W, Pan Y-CE, Tsang TC, Stern D: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
10. Li YM, Mitsuhashi T, Wojciechowicz, D, Shimizu N, Li J, Stitt A, He CJ, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to ost-48 and p90 to 80k-h membrane proteins. Proc Natl Acad Sci USA 93:11047-11052, 1996
11. Li YM, Tan AX, Vlassara H: Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med 1:1057-1061, 1995
12. Bucala R, Vlassara H: Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26:875-888, 1995
13. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G: Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50:627-634, 1996
14. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE: Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products. J Clin Invest 99:1016-1027, 1997
15. Bunag; RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282, 1973
16. Dean R, Zhuo JL, Alcorn D, Casley D, Mendelsohn Fao: Cellular localization of endothelin receptor subtypes in the rat kidney following in vitro labelling. Clin Exp Pharmacol Physiol 23:524-531, 1996
17. Harris PJ, Cooper ME, Hiranyachattada S, Berka JL, Kelly DJ, Nobes M, Wookey PJ: Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. Am J Physiol 41:F13-F21, 1997
18. Leavitt RD, Felsted RL, Bachur NR: Biological and biochemical properties of phaseolus vulgaris isolectins. J Biol Chem 252:2961-2966, 1977
19. Wookey PJ, Tikellis C, Nobes M, Casley D, Cooper ME, Darby IA: Amylin as a growth factor during fetal and postnatal development of the rat kidney. Kidney Int 53:25-30, 1998
20. Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum O, Jerums G: Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia 40:1141-1151, 1997
21. Munson DJ, Rodbard D: Ligand: A versatile computerised approach for the characterisation of ligand binding systems. Anal Biochem 107:220-239, 1980
22. Bierhaus A, Ritz E, Nawroth RP: Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease. Nephrol Dial Transplant 11:87-90, 1996
23. Gugliucci A, Bendayan M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39:149-160, 1996
24. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40:619-628, 1997
25. Lin S, Huang Y: Receptor for advanced glycation end-products is upregulated within diabetic kidney tissue: Potential role in diabetic nephropathy. (abstract) J Am Soc Nephrol 7:1874, 1996
26. Ziyadeh FN, Cohen MP, Guo J, Jin YL: RAGE mRNA expression in the diabetic mouse kidney. Mol Cell Biochem 170:147-152,1997
27. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H: Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: Relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174:515-524, 1991
28. He C-J, Stitt A, Striker L, Plattori M, Vlassara H: Low expression of AGE-receptor-1 in NOD mouse mesangial cells: Possible link to diabetic nephropathy. (abstract) J Am Soc Nephrol 7:1871, 1996
29. Mitsuhashi T, Vlassara H, Founds HW, Li YM: Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Methods 207:79-88, 1997
30. Vlassara H, Brownlee M, Cerami A: Novel macrophage receptor for glucose-modified protein is distinct from previously described scavenger receptors. J Exp Med 164:1302-1309, 1986
31. Sexton PM, Paxinos G, Kenney Ma, Wookey PJ, Beaumont K: In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62:553-567, 1994
32. Hill MA, Ege EA: Active and passive mechanical properties of isolated arterioles from STZ-induccd diabetic rats: Effect of aminoguanidine treatment. Diabetes 43:1450-1456, 1994
33. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438, 1991
34. Wells-Knecht KJ, Brinkmann E, Wellsknecht MC, Litchfield JE, Ahmed MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW: New biomarkers of maillard reaction damage to proteins. Nephrol Dial Transplant 11:41-47, 1996
35. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, Destrihou CV, Kurokawa K: Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney Int 53:416-422, 1998
36. Simm A, Munch G, Seif F, Schenk O, Heidland A, Richter H, Vamvakas S, Schinzel R: Advanced glycation endproducts stimulate the map-kinase pathway in tubulus cell line llc-pk1. FEBS Lett 410:481-484, 1997
37. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
38. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
39. Sakai H, Jinde K, Suzuki D, Yagame M, Nomoto Y: Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Nephrol Dial Transplant 11:66-71, 1996
40. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
41. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E: Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92:747-750, 1996
42. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang JH. Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1 ) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995
43. Kochakian M, Manjula BN, Egan JJ: Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats. Diabetes 45:1694-1700, 1996
44. Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P: An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382:275-278, 1996